Understanding Comorbid Substance Use Disorders and Serious Mental Illness-Lecture Presentation

Video Transcription

Video Summary

In this video, Amy Cohen, a member of the Clinical Expert Team with SMI Advisor, introduces a webinar on understanding co-occurring substance use disorders and serious mental illness. The webinar is led by Amanda Simonton, a psychiatric mental health nurse practitioner, and Dr. Donna Rowland, a Clinical Associate Professor. The video discusses the prevalence and definitions of substance use disorders as defined by the American Society of Addiction Medicine and the DSM-5. It highlights the high rates of comorbidity between substance use disorders and serious mental illness, as well as the impact of substance use on mental health. The video emphasizes the importance of screening for substance use disorders and provides an overview of screening tools, such as the CAGE questionnaire and the CRAFT screening tool for adolescents. It also explores treatment options for substance use disorders, including medication-assisted treatment (MAT) with drugs like methadone, buprenorphine, and naltrexone. The video concludes by discussing motivational interviewing as an effective counseling style for individuals with substance use disorders, and highlights the importance of language and stigma reduction in treating these issues.

Keywords

Amy Cohen

SMI Advisor

Amanda Simonton

Dr. Donna Rowland

substance use disorders

serious mental illness

DSM-5

medication-assisted treatment